Moderna Crash Wipes Out Over $20 Billion In Market Value After Concerns Stock Is Overhyped

Published 3 years ago
In this photo illustration the medical syringe is seen with

TOPLINE: What had been a booming Moderna stock price took a major step backward Wednesday, falling more than 15% on the heels of an analyst’s warning that the stock’s soaring price was an “unrealistic valuation” based on hype around the company’s Covid vaccine.

KEY FACTS

Moderna’s price closed at $385.33 on Wednesday, after closing at more than $450 on Tuesday.

The drop marks the second-straight day Moderna’s stock has fallen, following a scathing analysis from Bank of America’s Geoff Meacham on Monday.

Advertisement

The analysis called Moderna’s price “ridiculous” and “unjustifiable on a fundamental basis,” noting the 11-year-old company’s market cap had exceeded those of drug companies that are over a century old.

Meacham placed his price target at $115—more than 75% lower than the price at Monday’s close.

Loading...

Even with losses over the past two days, the stock’s price is still up more than 65% over the past month alone and around 450% from last year.

CRUCIAL QUOTE

“We continue to view current levels as unjustifiable on a fundamental basis, despite remaining positive on mRNA technology,” Meacham said.

Advertisement

KEY BACKGROUND

Moderna has been a massive supplier to the Covid-19 vaccination effort in the U.S., with its doses accounting for more than 140 million of the shots administered in the U.S., according to the CDC. Only Pfizer and BioNTech have supplied more vaccines, accounting for just short of 198 million doses. But the rate of vaccination in the U.S. is significantly below what it was during the spring, despite a slight uptick over the past few weeks, and the Bank of America analysis noted health officials are still advising that booster shots are not yet needed.

TANGENT

Prices of Pfizer and BioNTech also dropped significantly on Wednesday, though not as much as Moderna’s. Pfizer’s price dropped 3.9%, BioNTech’s nearly 14%.

Advertisement

Loading...

African Billionaires in 2025

Click on a billionaire to view their profile

RANK: 1
Aliko Dangote
Aliko Dangote
NET WORTH: $23.9 BTREND:
COUNTRY: Nigeria
RANK: 2
Johann Rupert & family
Johann Rupert & family
NET WORTH: $14 BTREND:
COUNTRY: South Africa
RANK: 3
Nicky Oppenheimer & family
Nicky Oppenheimer & family
NET WORTH: $10.4 BTREND:
COUNTRY: South Africa
RANK: 4
Nassef Sawiris
Nassef Sawiris
NET WORTH: $9.6 BTREND:
COUNTRY: Egypt
RANK: 5
Mike Adenuga
Mike Adenuga
NET WORTH: $6.8 BTREND:
COUNTRY: Nigeria
RANK: 6
Abdulsamad Rabiu
Abdulsamad Rabiu
NET WORTH: $5.1 BTREND:
COUNTRY: Nigeria
RANK: 7
Naguib Sawiris
Naguib Sawiris
NET WORTH: $5 BTREND:
COUNTRY: Egypt
RANK: 8
Koos Bekker
Koos Bekker
NET WORTH: $3.4 BTREND:
COUNTRY: South Africa
RANK: 8
Mohamed Mansour
Mohamed Mansour
NET WORTH: $3.4 BTREND:
COUNTRY: Egypt
RANK: 10
Patrice Motsepe
Patrice Motsepe
NET WORTH: $3 BTREND:
COUNTRY: South Africa
RANK: 10
Issad Rebrab & family
Issad Rebrab & family
NET WORTH: $3 BTREND:
COUNTRY: Algeria
RANK: 12
Mohammed Dewji
Mohammed Dewji
NET WORTH: $2.2 BTREND:
COUNTRY: Tanzania
RANK: 12
Michiel Le Roux
Michiel Le Roux
NET WORTH: $2.2 BTREND:
COUNTRY: South Africa
RANK: 14
Othman Benjelloun & family
Othman Benjelloun & family
NET WORTH: $1.6 BTREND:
COUNTRY: Morocco
RANK: 14
Anas Sefrioui & family
Anas Sefrioui & family
NET WORTH: $1.6 BTREND:
COUNTRY: Morocco
RANK: 16
Aziz Akhannouch & family
Aziz Akhannouch & family
NET WORTH: $1.5 BTREND:
COUNTRY: Morocco
RANK: 16
Femi Otedola
Femi Otedola
NET WORTH: $1.5 BTREND:
COUNTRY: Nigeria
RANK: 16
Christoffel Wiese
Christoffel Wiese
NET WORTH: $1.5 BTREND:
COUNTRY: South Africa
RANK: 20
Youssef Mansour
Youssef Mansour
NET WORTH: $1.4 BTREND:
COUNTRY: Egypt
RANK: 21
Yasseen Mansour
Yasseen Mansour
NET WORTH: $1.2 BTREND:
COUNTRY: Egypt
RANK: 21
Strive Masiyiwa
Strive Masiyiwa
NET WORTH: $1.2 BTREND:
COUNTRY: Zimbabwe